It is with great pleasure that the Personalised Medicine Network announces that the 3rd International Moesgaard Conference will be held in Aarhus on 5…
Side 9 af 9
Ny professor ved Institut for Klinisk Medicin, Aarhus Universitet
Innovativ lægemiddel udvikling uden serendipitet - Er det muligt?
Prognosis in acute myeloid leukemia: Impact of time-to-treatment, non-hematological comorbidity, secondary and therapy-related leukemia.
Side 431 af 484